Significant Ownership of Raymond Prudo-Chlebosz

Signature - Title: /s/ Ray Prudo - Reporting Person
Location: London, United Kingdom
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by Raymond Prudo-Chlebosz.

Notify me when Raymond Prudo-Chlebosz files a new Schedule 13D/G report.

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
AKTX	Akari Therapeutics, Plc	Ordinary Shares, $0.0001 par value	9.3%	$6.9B		4.93B		Ray Prudo, M.D.	Nov 14, 2024

Schedules 13D/G Reported by Raymond Prudo-Chlebosz:

Sym	Target	Class	Ownership	Change	Current Shares	Change	Value	Reporting name	Form	Report Period	Date Filed

* An asterisk sign (*) next to the price indicates that the price is likely invalid.